First Indian Consensus on Managing Refractory Gastroesophageal Reflux Disease Recommends Vonoprazan Deeksha Bhandari15 May 2025 12:42 PM ISTA recent expert group consensus has endorsed the use of vonoprazan for managing refractory gastroesophageal reflux disease (rGERD) in Indian...
Ajanta Pharma Sets Worldwide Record for CPR Pledges MDTV Bureau9 May 2025 5:22 PM ISTAjanta Pharma has achieved a significant milestone by entering the Worldwide Book of Records for organizing the maximum number of pledges to train and...
Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali Deeksha Bhandari9 May 2025 12:00 PM ISTCancer and chemotherapy-induced anemia (CIA) is a common complication in patients undergoing active chemotherapy, with or without radiation therapy....
7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice Deeksha Bhandari3 May 2025 12:41 PM ISTA recent consensus & expert recommendations published in the Primary Care Respiratory Medicine journal has revealed insightful facts. ...
Biosimilar Denosumab of Alkem (Denuril) shows Comparable Efficacy in Treating Postmenopausal Osteoporosis in Indian Women Deeksha Bhandari12 April 2025 12:19 PM ISTBiosimilar denosumab of Alkem (Denuril) showed comparable efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity to the innovator...
BRESER Study Demonstrates Real-World Efficacy and Safety of Lupin's Ranibizumab Biosimilar (Ranieyes) Deeksha Bhandari11 April 2025 11:24 AM ISTRanieyes is the Ranibizumab Biosimilar which is an Indian Ranibizumab Biosimilar manufactured by Lupin Ltd & approved in India for various...
Darbepoetin alfa (Cresp) for Chemotherapy-induced Anemia: Study Highlights with Dr MV Chandrakanth Deeksha Bhandari10 April 2025 12:30 PM ISTAnemia remains a pervasive yet often underappreciated complication among cancer patients undergoing chemotherapy, significantly impacting their...
Right Turn Show- Exploring Dapagliflozin Beyond Glycemic Benefits Deeksha Bhandari8 April 2025 12:34 PM ISTIn the last episode, we explored the role of Dapagliflozin in specialty care settings. Moving forward, this episode delves into Dapagliflozin Beyond...
Darbepoetin alfa (Cresp) Boosts Hemoglobin Levels in Chemotherapy-Induced Anemia (CIA): Results of Indian Analysis Deeksha Bhandari4 April 2025 11:58 AM ISTDarbepoetin alfa effectively increases hemoglobin levels and reduces blood transfusion needs among chemotherapy-induced anemia (CIA) patients,...
USV Launches Empagliflozin Range Under Xenia Brand Deeksha Bhandari2 April 2025 12:23 PM ISTUSV Pvt. Ltd., a leader in diabetes care, has announced the launch of its Xenia brand range in India, following the patent expiry of Empagliflozin. ...
Lupin Launches Ajaduo M Forte, a Triple Fixed-Dose Combination of Empagliflozin, Linagliptin, and Metformin Extended Release (ER) MDTV Bureau31 March 2025 10:15 AM ISTGlobal pharmaceutical company Lupin Limited has announced the launch of Ajaduo M Forte, a novel triple fixed-dose combination (FDC) therapy for the...
USV Expands Diabetes Portfolio with Cost-Effective Liralin-EP in India Deeksha Bhandari22 March 2025 1:00 PM ISTUSV Pvt. Ltd., launches the Liralin EP a combination of Linagliptin & Empagliflozin at just Rs 12.90 per tablet for strengthening it's affordable...
